Product Information
TERIPARATIDE 560 MCG/2.24 ML PEN is a generic product labeled by Amphastar Pharmaceuticals, Inc., priced at $479.9511 per ML under NDC 00548231100. Its NADAC has been published 32 times since Feb 25, 2026.
FDA first approved this application on Dec 12, 2025. Its Orange Book therapeutic-equivalence code is AP.
Strength
250 ug/mL
Manufacturer
Amphastar Pharmaceuticals, Inc.NDC
00548231100
Classification
Generic
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
TERIPARATIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213641FDA Approved
12/12/2025
TE Code
AP
On Market Since
12/22/2025
Pharmacological Classes
Price Statistics
The NADAC for TERIPARATIDE 560 MCG/2.24 ML PEN has been published 32 times since Feb 25, 2026, and over the history we have for it it has declined 23.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $479.9511 per ML |
|---|---|
| All-time high | $624.8910 (Mar 11, 2026) |
| All-time low | $479.9511 (Sep 23, 2026) |
| 52-week high | $624.8910 |
| 52-week low | $479.9511 |
| Median price | $536.5490 |
| Average price | $542.3307 |
| Largest weekly change | -9.3% (Apr 22, 2026) |
| Weeks tracked | 32 |
| Tracking since | Feb 25, 2026 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amphastar Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Teriparatide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Parathyroid Hormone Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TERIPARATIDE 560 MCG/2.24 ML PEN?
The current National Average Drug Acquisition Cost (NADAC) for TERIPARATIDE 560 MCG/2.24 ML PEN, manufactured by Amphastar Pharmaceuticals, Inc., is $479.9511 per ML (NDC 00548231100), effective Sep 30, 2026.
How has the price of TERIPARATIDE 560 MCG/2.24 ML PEN changed over time?
Over the history we have for it, the NADAC for TERIPARATIDE 560 MCG/2.24 ML PEN has declined 23.2%. It has been tracked across 32 weekly CMS publications since Feb 25, 2026.
What are the highest and lowest recorded NADAC prices for TERIPARATIDE 560 MCG/2.24 ML PEN?
Since Feb 25, 2026, the NADAC for TERIPARATIDE 560 MCG/2.24 ML PEN has ranged from a low of $479.9511 (Sep 23, 2026) to a high of $624.8910 (Mar 11, 2026), with a median of $536.5490 per ML.
Are there cheaper alternatives to TERIPARATIDE 560 MCG/2.24 ML PEN?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TERIPARATIDE 560 MCG/2.24 ML PEN in a comparable dosage form, but none are currently priced below it.
Who manufactures TERIPARATIDE 560 MCG/2.24 ML PEN?
TERIPARATIDE 560 MCG/2.24 ML PEN (NDC 00548231100) is labeled by Amphastar Pharmaceuticals, Inc., and CMS classifies it as a generic product.